Primary thyroid diffuse large B-cell lymphoma: a case report and focused review of the literature. (PubMed, Ann Hematol) - Oct 10, 2026 - "Treatment with R-CHOP and CNS prophylaxis achieved complete remission...Reported 5-year overall survival rates ranged from 57% to 88%, whereas relapse or refractory disease and central nervous system involvement were rare. Registry-based studies, especially those focusing on primary extranodal DLBCL, are necessary to develop evidence-based treatment guidelines for these patients."
Journal • Review • B Cell Lymphoma • CNS Disorders • Cough • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Otorhinolaryngology • Pulmonary Disease • Respiratory Diseases
|
|
Carsten Bokemeyer; Katja Weisel; Kürsat Kirkgöz; Susanne von Kroge
|